ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2020
Current Perspectives on the Impact of the National Diabetes Prevention Program: Building on Successes and Overcoming Challenges.
Review in Diabetes, metabolic syndrome and obesity : targets and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07392008 (PASO A PASO Pilot Study), which is not on this map. Cited by 42 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
PASO A PASO Pilot Study: Tailored Diabetes Prevention Program for Spanish-Speaking Communities Feasibility Study
Who cites it
42 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Pooled it
- Lower-Intensity Interventions for Prediabetes: A Systematic Review.American journal of preventive medicine · 2023Pooled it
- Start-Up and Implementation Costs for a Community-Based Culturally Tailored Diabetes Prevention Program.Journal of prevention (2022) · 2026Article
- Remembering What We Always Knew: Development of an Indigenous Diabetes Prevention Model.Current developments in nutrition · 2026Article
- Type 2 diabetes prevention programs at the community and municipal level: a scoping review of controlled intervention studies.BMC public health · 2026Article
- Geographic Analysis of Access to the National Diabetes Prevention Program in New York State.Preventive medicine reports · 2026Article
- Searching for type 2 diabetes prevention interventions in public health and community settings: protocol for a scoping review.BMJ open · 2026Article
- Epidemiological trends and burden of osteoarthritis in the United States: insights from the GBD 2021 study.Archives of medical science : AMS · 2026Article
- Questioning the status quo: Latino community members as researchers in the study of health equity.Psychotherapy (Chicago, Ill.) · 2025Article
- Assessing the Fit of a Digitally Delivered National Diabetes Prevention Program Among Rural Living Adults: Qualitative Study.JMIR formative research · 2025Article
- Engagement in the National Diabetes Prevention Program Among Hispanic Men.JAMA network open · 2025Article
- Development and validation of a type 2 diabetes model to estimate the cost-effectiveness of diabetes interventions across the care continuum.International journal of technology assessment in health care · 2025Article
- Navigating CDC recognition for the National DPP in socially vulnerable communities: barriers, facilitators, and recommendations.Archives of public health = Archives belges de sante publique · 2025Article
- Diabetes beliefs, perceived risk and health behaviours: an embedded mixed-methods analysis from the Richmond Stress and Sugar Study.BMJ open · 2025Article
- Investigating the Delivery of the National Diabetes Prevention Program to Latines: Coaches' Perspectives.Translational behavioral medicine · 2025Article
- Lifestyle interventions for cardiometabolic health.Nature medicine · 2024Review
- Enhancing access and impact of the Medicare Diabetes Prevention Program using telehealth: a narrative review.mHealth · 2024Review
- A virtual recruitment protocol promotes enrollment of underrepresented groups in a diabetes prevention trial.Journal of clinical and translational science · 2024Article
- Delivering the National Diabetes Prevention Program: Assessment of Retention, Physical Activity, and Weight Loss Outcomes by Participant Characteristics and Delivery Modes.Journal of diabetes research · 2024Article
- Primary care providers' perspectives on referrals to the Diabetes Prevention Programme: a qualitative comparative study across varied referral patterns.BMJ nutrition, prevention & health · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
To address the public health and economic burden of type 2 diabetes, the Centers for Disease Control and Prevention (CDC) began dissemination of the National Diabetes Prevention Program (NDPP) in the United States in 2010. Based on the intensive lifestyle intervention from a large efficacy trial, the NDPP aims to reduce incidence through lifestyle change and weight loss. This narrative review summarizes evidence on reach, effectiveness, and sustainability of the NDPP, while highlighting opportunities to overcome challenges in these areas. Major successes include reaching hundreds of thousands of at-risk individuals across the nation, with notable effectiveness upon full participation and widespread insurance coverage. Yet, more work is needed to ensure greater public health impact, particularly among priority populations at heightened risk who also experience disparities in program outcomes. Preliminary evidence suggests a number of strategies may improve reach and effectiveness of the NDPP, often with more rigorous study needed prior to widespread uptake. Updating the NDPP to better match the current evidence-base may also be important, such as directly targeting glycemia with a patient-centered approach and promoting metformin as an adjunct or second-line treatment. Finally, revisiting pay-for-performance reimbursement models may be critical to sustainability by ensuring adequate availability of suppliers and ultimately reducing diabetes prevalence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.